BRIEF-Sesen Bio Got Determination From Nasdaq That Co Granted An Exception From Its Non-Compliance With $1 Bid Price Requirement

Reuters2023-02-27

Feb 27 (Reuters) - Sesen Bio Inc :

* ON FEB 24, GOT DETERMINATION FROM NASDAQ THAT CO GRANTED AN EXCEPTION FROM ITS NON-COMPLIANCE WITH $1.00 BID PRICE REQUIREMENT

* WAS EXCEPTION FROM NON-COMPLIANCE WITH THE $1.00 BID PRICE REQUIREMENT TO COMPLETE PROPOSED MERGER WITH CARISMA THERAPEUTICS INC

Further company coverage:

((Reuters.Briefs@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2314554601?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2023-02-27 21:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2314554601","market":"us","top_or_hot":-1,"title":"BRIEF-Sesen Bio Got Determination From Nasdaq That Co Granted An Exception From Its Non-Compliance With $1 Bid Price Requirement","media":"Reuters","content":"<html><body><p>Feb 27 (Reuters) - Sesen Bio Inc   :</p><p>   * ON FEB 24, GOT DETERMINATION FROM NASDAQ THAT CO GRANTED AN EXCEPTION FROM ITS NON-COMPLIANCE WITH $1.00 BID PRICE REQUIREMENT</p><p>   * WAS EXCEPTION FROM NON-COMPLIANCE WITH THE $1.00 BID PRICE REQUIREMENT TO COMPLETE PROPOSED MERGER WITH CARISMA THERAPEUTICS INC</p><p> Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Sesen Bio Got Determination From Nasdaq That Co Granted An Exception From Its Non-Compliance With $1 Bid Price Requirement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Sesen Bio Got Determination From Nasdaq That Co Granted An Exception From Its Non-Compliance With $1 Bid Price Requirement\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-02-27 21:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Feb 27 (Reuters) - Sesen Bio Inc   :   * ON FEB 24, GOT DETERMINATION FROM NASDAQ THAT CO GRANTED AN EXCEPTION FROM ITS NON-COMPLIANCE WITH $1.00 BID PRICE REQUIREMENT   * WAS EXCEPTION FROM NON-...</p>\n\n<a href=\"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LHDX","symbol_name":"Lucira Health, Inc.","start_time":0,"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2314554601","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2314554601","pubTimestamp":1677504512,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"Feb 27 (Reuters) - Sesen Bio Inc   :   * ON FEB 24, GOT DETERMINATION FROM NASDAQ THAT CO GRANTED AN","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LHDX":"Lucira Health, Inc.","QLD":"纳指两倍做多ETF","BK4007":"制药","BK4196":"保健护理服务","BK4082":"医疗保健设备","SQQQ":"纳指三倍做空ETF",".IXIC":"NASDAQ Composite","QQQ":"纳指100ETF","TQQQ":"纳指三倍做多ETF","PSQ":"纳指反向ETF","SANA":"Sana Biotechnology, Inc.","QID":"纳指两倍做空ETF","BK4023":"应用软件","LABP":"Landos Biopharma, Inc.","CGEM":"Cullinan Therapeutics","CARM":"Carisma Therapeutics","ONTF":"ON24, Inc.","BK4139":"生物科技","APR":"Apria, Inc."},"translate_title":"简介-Sesen Bio从纳斯达克获得裁定，Co批准其不遵守1美元投标价格要求的例外情况","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"APR":0.9,"SESN":0.9,"SANA":0.9,"ONTF":0.9,"LHDX":0.9,"LABP":0.9,"CGEM":0.9,"CARM":0.9,".IXIC":0.69,"MNQmain":0.6,"NQmain":0.6,"PSQ":0.6,"QID":0.6,"QLD":0.6,"QQQ":0.6,"SQQQ":0.6,"TQQQ":0.6},"content_text":"Feb 27 (Reuters) - Sesen Bio Inc   :   * ON FEB 24, GOT DETERMINATION FROM NASDAQ THAT CO GRANTED AN EXCEPTION FROM ITS NON-COMPLIANCE WITH $1.00 BID PRICE REQUIREMENT   * WAS EXCEPTION FROM NON-COMPLIANCE WITH THE $1.00 BID PRICE REQUIREMENT TO COMPLETE PROPOSED MERGER WITH CARISMA THERAPEUTICS INC Further company coverage:    ((Reuters.Briefs@thomsonreuters.com))","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.28.1","shortVersion":"4.28.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2314554601"}